Pharmaron

Forecast & Rating13 analysts currently cover Pharmaron, with about 76.9% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥37.73, about 0.6% upside from the current price of ¥37.50. Price targets range from ¥23.80 to ¥46.16 — a wide spread, showing clear disagreement over just how much Pharmaron can rise. Historically, about 65.1% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Pharmaron closely still see room for the stock to rise. Data as of Jul 25, 2026; for reference only and not investment advice.